Suppr超能文献

利用人间质干细胞和脱落乳牙细胞片开发腭骨。

Developing palatal bone using human mesenchymal stem cell and stem cells from exfoliated deciduous teeth cell sheets.

机构信息

Division in Anatomy and Developmental Biology, Department of Oral Biology, Oral Science Research Center, BK21 PLUS Project, Yonsei University College of Dentistry, Seoul, Korea.

Institute of Advanced Biomedical Engineering and Science, Tokyo Women's Medical University, Tokyo, Japan.

出版信息

J Tissue Eng Regen Med. 2019 Feb;13(2):319-327. doi: 10.1002/term.2811. Epub 2019 Jan 30.

Abstract

Cleft palate is one of the most common craniofacial defects in newborn babies. The characteristics of this genetic disease produce soft and hard tissue defects on the lip and maxilla, which cause not only aesthetic but also functional problems with speech, eating, and breathing. Bone grafts using autologous cancellous bone have been a standard treatment to repair the hard tissue defect in cleft palates. However, such grafts do not fully integrate into host bone and undergo resorption. To overcome engraftment problems, it is common to engineer new tissues with a combination of multipotent cells and biomaterial frameworks. Here, we manufactured cell sheets for bone repair of cleft palates derived from two osteogenic cell sources, human mesenchymal stem cells (hMSCs) and stem cells from human exfoliated deciduous teeth (SHEDs). Cell sheets made from hMSCs and SHEDs gave rise to in vitro calcification, which indicated the osteogenic potential of these cells. The cell sheets of hMSCs and SHEDs expressed the bone-specific osteogenic markers, osterix, osteocalcin, and osteopontin, following insertion into ex vivo-cultured embryonic palatal shelves and in ovo culture. In conclusion, we showed that osteogenic stem cell sheets have mineralization potential and might represent a new alternative to autologous bone transplantation in the reconstruction of cleft palates.

摘要

腭裂是新生儿最常见的颅面畸形之一。这种遗传性疾病的特征是在唇和上颌产生软、硬组织缺陷,不仅会导致美观问题,还会导致言语、进食和呼吸等功能问题。使用自体松质骨进行骨移植已成为修复腭裂硬组织缺陷的标准治疗方法。然而,这种移植骨并不能完全与宿主骨融合,而是会发生吸收。为了克服移植物的问题,通常采用多能细胞和生物材料支架相结合的方法来构建新的组织。在这里,我们制造了源自两种成骨细胞源(人骨髓间充质干细胞(hMSCs)和人脱落乳牙牙髓干细胞(SHEDs))的腭裂骨修复用细胞片。hMSCs 和 SHEDs 制成的细胞片在体外发生钙化,这表明这些细胞具有成骨潜能。hMSCs 和 SHEDs 的细胞片在插入体外培养的胚胎腭架和鸡胚培养后表达了骨特异性成骨标志物,骨钙素、骨桥蛋白。总之,我们表明成骨干细胞片具有矿化潜力,可能成为腭裂重建中自体骨移植的新替代方法。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验